Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.
about
High IDO-1 expression in tumor endothelial cells is associated with response to immunotherapy in metastatic renal cell carcinoma.Optimized Expression and Characterization of a Novel Fully Human Bispecific Single-Chain Diabody Targeting Vascular Endothelial Growth Factor165 and Programmed Death-1 in and Evaluation of Antitumor Activity In Vivo
P2860
Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@en
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@nl
type
label
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@en
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@nl
prefLabel
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@en
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@nl
P2093
P2860
P921
P356
P1476
Synergies of Targeting Tumor A ...... Concepts to Clinical Reality.
@en
P2093
Andreas Pircher
Axel Heidenreich
Dominik Wolf
Isabel Heidegger
Renate Pichler
Wolfgang Hilbe
P2860
P356
10.3390/IJMS18112291
P407
P5008
P577
2017-10-31T00:00:00Z